320 related articles for article (PubMed ID: 11017088)
21. Family MRX9 revisited: further evidence for locus heterogeneity in MRX.
Winnepenninckx B; Errijgers V; Reyniers E; De Deyn PP; Abidi FE; Schwartz CE; Kooy RF
Am J Med Genet; 2002 Sep; 112(1):17-22. PubMed ID: 12239714
[TBL] [Abstract][Full Text] [Related]
22. Genetic localisation of MRX27 to Xq24-26 defines another discrete gene for non-specific X-linked mental retardation.
Gedeon AK; Glass IA; Connor JM; Mulley JC
Am J Med Genet; 1996 Jul; 64(1):121-4. PubMed ID: 8826461
[TBL] [Abstract][Full Text] [Related]
23. X-linked nonspecific mental retardation (MRX16) mapping to distal Xq28: linkage study and neuropsychological data in a large family.
Gendrot C; Ronce N; Raynaud M; Ayrault AD; Dourlens J; Castelnau P; Muh JP; Chelly J; Moraine C
Am J Med Genet; 1999 Apr; 83(5):411-8. PubMed ID: 10232754
[TBL] [Abstract][Full Text] [Related]
24. Localization of human X chromosomal mental retardation (MRX) genes in chicken and comparison with the chicken genome sequence data.
Kohn M; Kehrer-Sawatzki H; Hameister H
Cytogenet Genome Res; 2005; 108(4):342-7. PubMed ID: 15627755
[TBL] [Abstract][Full Text] [Related]
25. Monogenic causes of X-linked mental retardation.
Chelly J; Mandel JL
Nat Rev Genet; 2001 Sep; 2(9):669-80. PubMed ID: 11533716
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation.
Kalscheuer VM; Freude K; Musante L; Jensen LR; Yntema HG; Gécz J; Sefiani A; Hoffmann K; Moser B; Haas S; Gurok U; Haesler S; Aranda B; Nshedjan A; Tzschach A; Hartmann N; Roloff TC; Shoichet S; Hagens O; Tao J; Van Bokhoven H; Turner G; Chelly J; Moraine C; Fryns JP; Nuber U; Hoeltzenbein M; Scharff C; Scherthan H; Lenzner S; Hamel BC; Schweiger S; Ropers HH
Nat Genet; 2003 Dec; 35(4):313-5. PubMed ID: 14634649
[TBL] [Abstract][Full Text] [Related]
27. A two base pair deletion in the PQBP1 gene is associated with microphthalmia, microcephaly, and mental retardation.
Martínez-Garay I; Tomás M; Oltra S; Ramser J; Moltó MD; Prieto F; Meindl A; Kutsche K; Martínez F
Eur J Hum Genet; 2007 Jan; 15(1):29-34. PubMed ID: 17033686
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of a novel Rho-specific guanine nucleotide exchange factor.
Blomquist A; Schwörer G; Schablowski H; Psoma A; Lehnen M; Jakobs KH; Rümenapp U
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):319-25. PubMed ID: 11085924
[TBL] [Abstract][Full Text] [Related]
29. Further linkage evidence for localization of mutational sites for nonsyndromic types of X-linked mental retardation at the pericentromeric region.
Robledo R; Melis P; Laficara F; Marchi J; Rinaldi A; Siniscalco M; Filippi G
Am J Med Genet; 1996 Jul; 64(1):107-12. PubMed ID: 8826459
[TBL] [Abstract][Full Text] [Related]
30. X-linked mental retardation, short stature, microcephaly and hypogonadism maps to Xp22.1-p21.3 in a Belgian family.
Van Esch H; Zanni G; Holvoet M; Borghgraef M; Chelly J; Fryns JP; Devriendt K
Eur J Med Genet; 2005; 48(2):145-52. PubMed ID: 16053905
[TBL] [Abstract][Full Text] [Related]
31. Pericentromeric genes for non-specific X-linked mental retardation (MRX).
Gedeon A; Kerr B; Mulley J; Turner G
Am J Med Genet; 1994 Jul; 51(4):553-64. PubMed ID: 7943039
[TBL] [Abstract][Full Text] [Related]
32. Regional localization of two genes for nonspecific X-linked mental retardation to Xp22.3-p22.2 (MRX49) and Xp11.3-p11.21 (MRX50).
Claes S; Vogels A; Holvoet M; Devriendt K; Raeymaekers P; Cassiman JJ; Fryns JP
Am J Med Genet; 1997 Dec; 73(4):474-9. PubMed ID: 9415477
[TBL] [Abstract][Full Text] [Related]
33. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
34. In vitro guanine nucleotide exchange activity of DHR-2/DOCKER/CZH2 domains.
Côté JF; Vuori K
Methods Enzymol; 2006; 406():41-57. PubMed ID: 16472648
[TBL] [Abstract][Full Text] [Related]
35. Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy.
Shimojima K; Sugawara M; Shichiji M; Mukaida S; Takayama R; Imai K; Yamamoto T
J Hum Genet; 2011 Aug; 56(8):561-5. PubMed ID: 21633362
[TBL] [Abstract][Full Text] [Related]
36. Nonspecific X-linked mental retardation II: the frequency in British Columbia.
Herbst DS; Miller JR
Am J Med Genet; 1980; 7(4):461-9. PubMed ID: 7211956
[TBL] [Abstract][Full Text] [Related]
37. [X-linked mental retardation--treatment scheme].
Lisik MZ; Sieroń AL
Wiad Lek; 2008; 61(4-6):146-53. PubMed ID: 18939366
[TBL] [Abstract][Full Text] [Related]
38. ARHGEF9 disruption in a female patient is associated with X linked mental retardation and sensory hyperarousal.
Marco EJ; Abidi FE; Bristow J; Dean WB; Cotter P; Jeremy RJ; Schwartz CE; Sherr EH
J Med Genet; 2008 Feb; 45(2):100-5. PubMed ID: 17893116
[TBL] [Abstract][Full Text] [Related]
39. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation.
Carrié A; Jun L; Bienvenu T; Vinet MC; McDonell N; Couvert P; Zemni R; Cardona A; Van Buggenhout G; Frints S; Hamel B; Moraine C; Ropers HH; Strom T; Howell GR; Whittaker A; Ross MT; Kahn A; Fryns JP; Beldjord C; Marynen P; Chelly J
Nat Genet; 1999 Sep; 23(1):25-31. PubMed ID: 10471494
[TBL] [Abstract][Full Text] [Related]
40. Localization of a gene for nonspecific X-linked mental retardation (MRX 76) to Xp22.3-Xp21.3.
Kleefstra T; Yntema HG; Oudakker AR; de Vries BB; van Bokhoven H; Hamel BC; Poppelaars FA; Ausems MG
Am J Med Genet; 2002 Jul; 110(4):410-1. PubMed ID: 12116222
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
